These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16216134)

  • 41. Autoinflammatory diseases: the hereditary periodic fever syndromes.
    Fietta P
    Acta Biomed; 2004 Aug; 75(2):92-9. PubMed ID: 15481697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene.
    Rittore C; Sanchez E; Soler S; Barat-Houari M; Albers M; Obici L; McDermott MF; Touitou I; Grandemange S
    Ann Rheum Dis; 2014 Jan; 73(1):290-7. PubMed ID: 23505244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22.
    Nakamura M; Tokura Y
    Eur J Dermatol; 2010; 20(4):508-9. PubMed ID: 20400394
    [No Abstract]   [Full Text] [Related]  

  • 44. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
    Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL
    Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever.
    Marek-Yagel D; Berkun Y; Padeh S; Lidar M; Shinar Y; Bar-Joseph I; Reznik-Wolf H; Langevitz P; Livneh A; Pras E
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1294-8. PubMed ID: 20506103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patients with tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) are hypersensitive to Toll-like receptor 9 stimulation.
    Negm OH; Singh S; Abduljabbar W; Hamed MR; Radford P; McDermott EM; Drewe E; Fairclough L; Todd I; Tighe PJ
    Clin Exp Immunol; 2019 Sep; 197(3):352-360. PubMed ID: 31009059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome.
    Kimberley FC; Lobito AA; Siegel RM; Screaton GR
    Arthritis Res Ther; 2007; 9(4):217. PubMed ID: 17666110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants.
    Mulazzani E; Wagner D; Havla J; Schlüter M; Meinl I; Gerdes LA; Kümpfel T
    J Neuroinflammation; 2020 Jun; 17(1):196. PubMed ID: 32563262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [From gene to disease; tumor necrosis factor receptor and a syndrome of familial periodic fever].
    Simon A; Drenth JP; van der Meer JW
    Ned Tijdschr Geneeskd; 2001 Jan; 145(2):77-8. PubMed ID: 11225261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: A differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin].
    Bourguiba R; Savey L; Aouba A; Deshayes S; Fain O; Martin-Silva N; Hentgen V; Desdoits A; Grateau G; Giurgea I; Georgin-Lavialle S
    Rev Med Interne; 2021 Jul; 42(7):459-464. PubMed ID: 33131906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.
    Dodé C; André M; Bienvenu T; Hausfater P; Pêcheux C; Bienvenu J; Lecron JC; Reinert P; Cattan D; Piette JC; Szajnert MF; Delpech M; Grateau G;
    Arthritis Rheum; 2002 Aug; 46(8):2181-8. PubMed ID: 12209523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics.
    Lainka E; Neudorf U; Lohse P; Timmann C; Stojanov S; Huss K; von Kries R; Niehues T
    Rheumatology (Oxford); 2009 Aug; 48(8):987-91. PubMed ID: 19541728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
    Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
    Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.
    Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R
    Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
    Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L
    Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Yousaf N; Chernajovsky Y; Stjernberg-Salmela S; Pettersson T; Ranki A; Hawkins PN; Arkwright PD; McDermott MF; Turner MD
    Arthritis Rheum; 2008 Jan; 58(1):273-83. PubMed ID: 18163488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients.
    Nakamura M; Kobayashi M; Tokura Y
    Br J Dermatol; 2009 Oct; 161(4):968-70. PubMed ID: 19673872
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene.
    Pelagatti MA; Meini A; Caorsi R; Cattalini M; Federici S; Zulian F; Calcagno G; Tommasini A; Bossi G; Sormani MP; Caroli F; Plebani A; Ceccherini I; Martini A; Gattorno M
    Arthritis Rheum; 2011 Apr; 63(4):1141-50. PubMed ID: 21225694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
    Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
    Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A family of tumor necrosis factor receptor-associated periodic syndrome].
    Li S; Ou RQ; Zhang BH; Zhang YN; Wang HY; Tan WP
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):477-482. PubMed ID: 31216807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.